SYK Stryker Earnings and EPS analysis

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 85

EPS in 2026 (TTM): $9.46

Last Report Period Date: Sep 30, 2026

As of November this year, based on Stryker's most recent financial report, the company's trailing twelve months EPS is $9.46. During 2025, SYK reported a per-share earnings of $8.49, which shows a rise compared to the EPS of $7.86 recorded in 2024. Stryker's EPS for the quarterly period ending on Sep 30, 2026 came in at $1.97.

SYK earnings history

Historical annual and quarterly earnings per share (EPS) data for Stryker
EPS (TTM)
$9.46
EPS Growth YoY (Quarterly)
-12.4%
EPS (Quarterly)
$1.97
EPS Growth (Quarterly)
-40.7%

The yearly earnings per share during 2025 was $8.49, a rise of 8% compared to $7.86 recorded in 2024. Over the quarter ending Sep 30, 2026, the earnings per share came in at $1.97, reflecting a 12.4% decline compared to the same quarter a year earlier. As of September 2026, the TTM EPS is $9.46. During 2024, the annual earnings per share was $7.86, representing a decrease of 5.8% compared to 2023.

SYK EPS vs price chart

SYK EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
-12.4%
EPS growth YoY
8%
EPS growth 3Y avg
10.9%
EPS growth 5Y avg
14.8%

Stryker has recorded a decline in earnings per share of 12.4% in the past 12 months (YoY, quarterly). Across the past three years, the company had an average EPS annual growth rate of 10.9% per year. Stryker had an average annual EPS growth of 14.8% in the last five years. When assessed over a ten-year period, SYK's average EPS annual growth was 8.3%.

SYK Earnings Waterfall

Breakdown of revenue, profit and net income for Stryker

SYK Earnings vs Peers

What are the earnings of SYK compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
GMED Globus Medical Inc - Class A 17.51 423.7% 28.2% 30.8%
BSX Boston Scientific Corp 18.59 55.6% 63.3% N/A
CNMD CONMED Corp 20.8 -64.6% N/A 35.7%
MDT Medtronic Plc 24.78 3.3% 9.8% 6.9%
SYK Stryker Corp 33.11 8% 10.9% 14.8%
JNJ Johnson & Johnson 42.62 90.6% 17.7% 14.8%
EW Edwards Lifesciences Corp 59.6 -73.6% -9.2% 6.9%
IART Integra Lifesciences Holdings Corp 83.91 -7,388.9% N/A N/A
WAT Waters Corp 191.31 0.5% -2.9% 5.2%
BAX Baxter International Inc N/A -47.2% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.